Whole Exome Sequencing
Deliver Precision Care with Clinical-Grade Accuracy
Empowering early answers that change outcomes.
When symptoms overlap, identifi WES brings genetic precision into focus. Powered by advanced sequencing and analytics, WES decodes all protein-coding regions – revealing the cause of most genetic disorders. It bridges the gap between clinical presentation & molecular understanding.
Why Choose identifi WES?
Every report delivers definitive genetic insight – built for clinical confidence
- 20,000 genes analyzed in one assay
- 100x coverage, 99% sensitivity, >99.9% specificity
- SNVs, Indels, and CNVs detected simultaneously
- NABL-accredited precision, benchmarked to ACMG/AMP/ACGS global standards
- Clinically actionable insights for diagnosis and clinical management
- Expert-reviewed reports delivered within 28 days
- Personalized pre and post genetic counseling by BCGI/IMA-certified experts, with dedicated patient support group management
Our proprietary identifi pipeline ensures deeper coverage, reduced false negatives, and actionable interpretation.
Clinical Impact
Cost-effective, broad-spectrum
Facilitates family cascade testing
Guides targeted therapy and management
Ends years of diagnostic uncertainty
Reveals the genetic basis of disease with clarity
As per American Academy of Pediatrics Guidelines (July 2025):
WES is the Tier I diagnostic test for children with developmental delay, intellectual disability, or unexplained seizures
identifi WES is recommended for
Complex or atypical symptoms
Suspected genetic/ hereditary disorders
Multiple congenital anomalies
Strong family history of genetic disease
Early onset hereditary cancer syndromes
Consanguineous families
Developmental delay or intellectual disability, unexpected epilepsy
Detects cause of recurrent fetal loss and guidance for next pregnancy
Negative or inconclusive prior genetic test
When identifi WES Adds Value
- When symptoms overlap specialties
- When family history signals hereditary risk
- When multiple tests remain inconclusive
- When precision guides therapy or prognosis
- When recurrent pregnancy loss suggests genetic etiology
- When abnormal screening needs confirmation
Evidence-Driven Interpretation
Integrates phenotype data for context-based variant analysis
Cross-verified with global databases OMIM, ClinVar, ClinGen, gnomAD
